Lipum (publ), a clinical stage biopharmaceutical company focused on chronic inflammatory diseases, today announced its participation in the following upcoming events.
BioStock Investor Meeting, 20 September, Stockholm, Sweden
Redeye theme: Autoimmune and Inflammatory Disease, 3 October, Stockholm, Sweden
Småbolagsdagen i Lund, Aktiespararna, 9 October, Lund, Sweden
BIO-Europe, 6–8 November, München, Germany
Umeå på börsen, 14 November, Umeå, Sweden
Redeye Life Science Day, 23 November 2023, Stockholm, Sweden
Nordic Life Science Days, 29-30 November 2023, Copenhagen, Denmark
"I look forward to these meetings. Our clinical study of the drug candidate SOL-116 is ongoing and the industry meetings provide great opportunities to present our progress.", says CEO Einar Pontén.